RxDoctor Payments DataLook up a doctor →

Wendell Helveston, MD

Neurology · Jackson, MSNPI 1881607158

Payments from drug & device makers

$883,254in general payments, 2019–2025

Across 2,486 payments — averaging $355.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$207K
  • AbbVie$169K
  • Biogen$82K
  • Amgen$69K
  • Jazz Pharmaceuticals Inc.$65K
  • SK Life Science, Inc.$62K
  • plus $229K from 54 others
$940in research payments, 2019–2025

Across 1 payment — averaging $940.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$940

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eisai Inc.284$207,026
AbbVie(2 entities)359$168,859
Biogen131$81,560
Amgen(2 entities)111$69,128
Jazz Pharmaceuticals Inc.94$64,722
SK Life Science, Inc.129$62,393
Lundbeck LLC128$60,573
Biohaven Pharmaceuticals, Inc.75$43,403
UCB, Inc.98$27,705
Genentech USA, Inc.67$24,683
Impel Pharmaceuticals Inc.27$16,614
Greenwich Biosciences, Inc.46$15,584
Biohaven Pharmaceutical Holding Company Ltd.38$11,371
Pfizer74$5,909
TG Therapeutics, Inc.19$2,830
Argenx US, Inc.35$2,793
Sunovion Pharmaceuticals Inc.50$2,680
Acadia Pharmaceuticals Inc75$1,349
Genentech, Inc.4$1,291
Teva Pharmaceuticals USA, Inc.72$1,176
Novartis80$1,168
EMD Serono, Inc.52$1,152
Neurocrine Biosciences, Inc.41$858
AstraZeneca(2 entities)42$795
Lilly USA, LLC59$785
Amneal Pharmaceuticals LLC6$774
MDD US Operations, LLC20$749
Acorda Therapeutics, Inc24$446
Sanofi23$425
CSL Behring17$332
ANI Pharmaceuticals, Inc.19$306
Otsuka America Pharmaceutical, Inc.11$303
Catalyst Pharmaceuticals, Inc.14$288
Livanova USA, Inc.1$250
Kyowa Kirin, Inc.11$197
Abbott2$193
Grifols USA, LLC9$191
GE HealthCare10$189
Johnson & Johnson11$173
Sumitomo Pharma America, Inc.11$171
Axsome Therapeutics, Inc.5$165
Adamas Pharmaceuticals, Inc.9$152
Merz Pharmaceuticals, LLC6$139
Tanabe Pharma America, Inc.6$123
Supernus Pharmaceuticals, Inc.8$122
Daiichi Sankyo Inc.6$117
Zogenix Inc.17$112
Octapharma USA, Inc.5$111
Neurelis, Inc.4$106
Alnylam Pharmaceuticals Inc.5$104
Mallinckrodt Hospital Products Inc.4$97
Avanir Pharmaceuticals, Inc.6$92
Upsher-smith Laboratories LLC6$84
Vanda Pharmaceuticals Inc.4$61
Takeda Pharmaceuticals U.S.A., Inc.2$55
Mallinckrodt Enterprises LLC3$44
Medtronic2$31
Currax Pharmaceuticals LLC2$29
Amylyx Pharmaceuticals, Inc.1$26
Promius Pharma LLC1$23

How this compares

$883,254 in reported general payments places this provider in the 95th percentile of 111 neurology providers in Mississippi.

See all neurology providers in Mississippi →

Medicare billing

Part B allowed, 2024
$3,371,729
Medicare patients
888
Services billed
515,597

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Jackson

See the full list for Mississippi →

Where these figures come from

Is this you, or does something look wrong? →